{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:40:35Z","timestamp":1789983635664,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00415-014-7350-7","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T07:01:05Z","timestamp":1398754865000},"page":"1387-1397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington\u2019s disease"],"prefix":"10.1007","volume":"261","author":[{"given":"Meike","family":"Herben-Dekker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C. H.","family":"van Oostrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline K.","family":"Jurgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle W.","family":"Witjes-An\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus P. H.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus L.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacoba M.","family":"Spikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"issue":"6","key":"7350_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"6","key":"7350_CR2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.69.6.773","volume":"69","author":"SC Kirkwood","year":"2000","unstructured":"Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T (2000) Subtle changes among presymptomatic carriers of the Huntington\u2019s disease gene. J Neurol Neurosurg Psychiatry 69(6):773","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"7350_CR3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.57.4.658","volume":"57","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Zhao H, Stout JC, Brinkman RR, Guttman M, Ross CA, Como P, Manning C, Hayden MR, Shoulson I, Huntington Study Group (2001) Clinical markers of early disease in persons near onset of Huntington\u2019s disease. Neurology 57(4):658\u2013662","journal-title":"Neurology"},{"key":"7350_CR4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnagi.2013.00012","volume":"5","author":"KM Biglan","year":"2013","unstructured":"Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group (2013) Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci 5:12. doi: 10.3389\/fnagi.2013.00012","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"7350_CR5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4(4):398\u2013403. doi: 10.1038\/ng0893-398","journal-title":"Nat Genet"},{"issue":"4","key":"7350_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, Folstein S, Ross C, Franz M, Abbott M et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4(4):387\u2013392. doi: 10.1038\/ng0893-387","journal-title":"Nat Genet"},{"issue":"4","key":"7350_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR, International Huntington\u2019s Disease Collaborative Group (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65(4):267\u2013277. doi: 10.1111\/j.1399-0004.2004.00241.x","journal-title":"Clin Genet"},{"issue":"8","key":"7350_CR8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2008) Detection of Huntington\u2019s disease decades before diagnosis: the PREDICT-HD study. J Neurol Neurosurg Psychiatry 79(8):874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"7350_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, TRACK-HD investigators (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801. doi: 10.1016\/S1474-4422(09)70170-X","journal-title":"Lancet Neurol"},{"issue":"1","key":"7350_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25(1):1\u201314. doi: 10.1037\/a0020937","journal-title":"Neuropsychology"},{"issue":"1","key":"7350_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, TRACK-HD investigators (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24\u00a0month observational data. Lancet Neurol 11(1):42\u201353. doi: 10.1016\/S1474-4422(11)70263-0","journal-title":"Lancet Neurol"},{"key":"7350_CR12","first-page":"199","volume":"63","author":"DE Kuhl","year":"1985","unstructured":"Kuhl DE, Markham CH, Metter EJ, Riege WH, Phelps ME, Mazziotta JC (1985) Local cerebral glucose utilization in symptomatic and presymptomatic Huntington\u2019s disease. Res Publ Assoc Res Nerv Ment Dis 63:199\u2013209","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"6","key":"7350_CR13","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Y\u00e9benez JG, Boesiger P, Weindl A, Maguire RP (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain J Neurol 119(6):2085\u20132095","journal-title":"Brain J Neurol"},{"issue":"11","key":"7350_CR14","first-page":"1591","volume":"42","author":"A Feigin","year":"2001","unstructured":"Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D (2001) Metabolic network abnormalities in early Huntington\u2019s disease: an [18F]FDG PET study. J Nucl Med 42(11):1591\u20131595","journal-title":"J Nucl Med"},{"issue":"6","key":"7350_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","volume":"65","author":"JCH Oostrom Van","year":"2005","unstructured":"Van Oostrom JCH, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Pruim J, Roos RAC, Leenders KL (2005) Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology 65(6):941\u2013943","journal-title":"Neurology"},{"issue":"11","key":"7350_CR16","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","volume":"130","author":"A Feigin","year":"2007","unstructured":"Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, Paulsen JS, Dhawan V, Eidelberg D (2007) Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease. Brain J Neurol 130(11):2858\u20132867","journal-title":"Brain J Neurol"},{"issue":"2","key":"7350_CR17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.expneurol.2008.12.015","volume":"216","author":"JS Paulsen","year":"2009","unstructured":"Paulsen JS (2009) Functional imaging in Huntington\u2019s disease. Exp Neurol 216(2):272\u2013277. doi: 10.1016\/j.expneurol.2008.12.015","journal-title":"Exp Neurol"},{"issue":"9","key":"7350_CR18","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","volume":"123","author":"CC Tang","year":"2013","unstructured":"Tang CC, Feigin A, Ma Y, Habeck C, Paulsen JS, Leenders KL, Teune LK, van Oostrom JCH, Guttman M, Dhawan V, Eidelberg D (2013) Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease. J Clin Investig 123(9):4076\u20134088. doi: 10.1172\/JCI69411","journal-title":"J Clin Investig"},{"issue":"2","key":"7350_CR19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","volume":"16","author":"JCH Oostrom Van","year":"2009","unstructured":"Van Oostrom JCH, Dekker M, Willemsen AT, De Jong BM, Roos RA, Leenders KL (2009) Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington\u2019s disease. Eur J Neurol 16(2):226\u2013231. doi: 10.1111\/j.1468-1331.2008.02390.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"7350_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Mov Disord 11(2):136\u2013142","journal-title":"Mov Disord"},{"issue":"3","key":"7350_CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"key":"7350_CR22","volume-title":"Intelligentie en leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar (Proefschrift)","author":"F Verhage","year":"1964","unstructured":"Verhage F (1964) Intelligentie en leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar (Proefschrift). Van Gorcum, Assen"},{"issue":"2","key":"7350_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mds.870110202","volume":"11","author":"N Quinn","year":"1996","unstructured":"Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, Lindvall O, MacMillan J, Roos R (1996) Core assessment program for intracerebral transplantation in Huntington\u2019s disease (CAPIT-HD). Mov Disord 11(2):143\u2013150","journal-title":"Mov Disord"},{"key":"7350_CR24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643\u2013662","journal-title":"J Exp Psychol"},{"key":"7350_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271\u2013276","journal-title":"Percept Mot Skills"},{"key":"7350_CR26","first-page":"83","volume":"3","author":"A Smith","year":"1968","unstructured":"Smith A (1968) The symbol digit modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 3:83\u201391","journal-title":"Learn Disord"},{"key":"7350_CR27","volume-title":"Multilingual aphasia examination","author":"AL Benton","year":"1976","unstructured":"Benton AL (1976) Multilingual aphasia examination. University of Iowa Press, Iowa City"},{"key":"7350_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00223980.1945.9917223","volume":"19","author":"DA Wechsler","year":"1945","unstructured":"Wechsler DA (1945) A standardized memory scale for clinical use. J Psychol 19:87\u201395","journal-title":"J Psychol"},{"issue":"2","key":"7350_CR29","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65\u201370","journal-title":"Scand J Stat"},{"issue":"7","key":"7350_CR30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR, The TRACK-HD Investigators (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637\u2013649. doi: 10.1016\/S1474-4422(13)70088-7","journal-title":"Lancet Neurol"},{"issue":"5","key":"7350_CR31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.44.5.823","volume":"44","author":"EH Aylward","year":"1994","unstructured":"Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ (1994) Reduced basal ganglia volume associated with the gene for Huntington\u2019s disease in asymptomatic at-risk persons. Neurology 44(5):823\u2013828","journal-title":"Neurology"},{"issue":"Pt 11","key":"7350_CR32","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/brain\/awm210","volume":"130","author":"RC Wolf","year":"2007","unstructured":"Wolf RC, Vasic N, Sch\u00f6nfeldt-Lecuona C, Landwehrmeyer GB, Ecker D (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington\u2019s disease: evidence from event-related fMRI. Brain nov 130(Pt 11):2845\u20132857 Epub 2007 sep 13","journal-title":"Brain nov"},{"key":"7350_CR33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp-2011-301732","volume":"83","author":"DL Harrington","year":"2012","unstructured":"Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, The PREDICT-HD Investigators of the Huntington Study Group (2012) Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 83:612\u2013619. doi: 10.1136\/jnnp-2011-301732","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7350_CR34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S1355617798455061","volume":"4","author":"JR Campodonico","year":"1998","unstructured":"Campodonico JR, Aylward E, Codori A, Yound C, Krafft L, Magdalinski M, Ranen N, Slavney PR, Brandt J (1998) When does Huntington\u2019s disease begin? J Int Neuropsychol Soc 4:467\u2013473","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"7350_CR35","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00415-008-0050-4","volume":"255","author":"CK Jurgens","year":"2008","unstructured":"Jurgens CK, van de Wiel L, van Es A, Grimbergen YM, Witjes-An\u00e9 MN, van der Grond J, Middelkoop HA, Roos RA (2008) Basal ganglia volume and clinical correlates in \u2018preclinical\u2019 Huntington\u2019s disease. J Neurol 255(11):1785\u20131791. doi: 10.1007\/s00415-008-0050-4","journal-title":"J Neurol"},{"issue":"2","key":"7350_CR36","first-page":"133","volume":"24","author":"JS Snowden","year":"2002","unstructured":"Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington\u2019s disease. Neuropsychol Dev Cognit Sect A 24(2):133","journal-title":"Neuropsychol Dev Cognit Sect A"},{"issue":"7","key":"7350_CR37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp-2011-301940","volume":"83","author":"JC Stout","year":"2012","unstructured":"Stout JC, Jones R, Labuschagne I, O\u2019Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, D\u00fcrr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C (2012) Evaluation of longitudinal 12 and 24\u00a0month cognitive outcomes in premanifest and early Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 83(7):687\u2013694. doi: 10.1136\/jnnp-2011-301940","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"7350_CR38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/jnp.2007.19.3.310","volume":"19","author":"MN Witjes-An\u00e9","year":"2007","unstructured":"Witjes-An\u00e9 MN, Mertens B, van Vugt JP, Bachoud-L\u00e9vi AC, van Ommen G, Roos RA (2007) Longitudinal evaluation of \u201cpresymptomatic\u201d carriers of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 19(3):310\u2013317","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7350-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7350-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7350-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:22:38Z","timestamp":1559071358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7350-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["7350"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7350-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}